Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SYD-4228 by Byondis for Mantle Cell Lymphoma: Likelihood of Approval
SYD-4228 is under clinical development by Byondis and currently in Phase I for Mantle Cell Lymphoma. According to GlobalData, Phase...
SYD-4228 by Byondis for Marginal Zone B-cell Lymphoma: Likelihood of Approval
SYD-4228 is under clinical development by Byondis and currently in Phase I for Marginal Zone B-cell Lymphoma. According to GlobalData,...
SYD-4228 by Byondis for Follicular Lymphoma: Likelihood of Approval
SYD-4228 is under clinical development by Byondis and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase I...
SYD-4228 by Byondis for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
SYD-4228 is under clinical development by Byondis and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to GlobalData,...